EP-A2- 1 932 536 (B1)

GERALD H. JORDAN: "The Use of Intralesional Clostridial Collagenase Injection Therapy for Peyronie's Disease: A Prospective, Single-Center, Non-Placebo-Controlled Study", JOURNAL OF SEXUAL MEDICINE, vol. 5, no. 1, 19 December 2007 (2007-12-19), pages 180-187, XP055012848, ISSN: 1743-6095, DOI: 10.1111/j.1743-6109.2007.00651.x (B1)

Hurst: "Injectable collagenase clostridium histolyticum for Dupuytren's contracture", The New England journal of medicine, 3 September 2009 (2009-09-03), XP055012764, Retrieved from the Internet: URL:http://www.nejm.org/doi/pdf/10.1056/NE JMoa0810866 [retrieved on 2011-11-22] (B1)

WO-A2-2007/089851 (B1)

Roche: "Liberase Research Grade Purified Enzyme Blends", Roche Applied Science Product , March 2011 (2011-03), 22 November 2011 (2011-11-22), pages 1-18, XP002664165, Retrieved from the Internet: URL:https://e-labdoc.roche.com/LFR_PublicD ocs/ras/05401119001_en_04.pdf [retrieved on 2011-11-22] (B1)

TATSUYA KIN ET AL: "Detrimental effect of excessive collagenase class II on human islet isolation outcome", TRANSPLANT INTERNATIONAL, vol. 21, no. 11, 1 July 2008 (2008-07-01), pages 1059-1065, XP055012776, ISSN: 0934-0874, DOI: 10.1111/j.1432-2277.2008.00734.x (B1)

US-A- 5 989 888 (B1)

LEE F ET AL: "An injectable hyaluronic acid-tyramine hydrogel system for protein delivery", JOURNAL OF CONTROLLED RELEASE, vol. 134, no. 3, 19 March 2009 (2009-03-19), pages 186-193, XP026049514, ELSEVIER, AMSTERDAM, NL ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2008.11.028 [retrieved on 2008-12-07] (B1)